Interim results from a phase I randomized, placebo-controlled trial of novel SARS-CoV-2 beta variant receptor-binding domain recombinant protein and mRNA …
TM Nolan, G Deliyannis, M Griffith, S Braat, LF Allen… - …, 2023 - thelancet.com
Background SARS-CoV-2 booster vaccination should ideally enhance protection against
variants and minimise immune imprinting. This Phase I trial evaluated two vaccines targeting …
variants and minimise immune imprinting. This Phase I trial evaluated two vaccines targeting …
Scientific highlights of the 9th ESWI Influenza Conference
L Reperant, CA Russell, A Osterhaus - One Health Outlook, 2024 - Springer
Abstract The European Scientific Working Group on Influenza (ESWI) held the 9th ESWI
Influenza Conference in Valencia from 17—20 September 2023. Here we provide a …
Influenza Conference in Valencia from 17—20 September 2023. Here we provide a …